Skip to main content

SSCP

Twitter Instagram Snapchat
0
Your Cart
No products in the cart.

Prioritizing Access to Modern Gene Therapies and Management Strategies for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy

  1. Home
  2. Prioritizing Access to Modern Gene Therapies and Management Strategies for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy
SS
SSCP Support
/
August 25, 2026

Prioritizing Access to Modern Gene Therapies and Management Strategies for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy

00
0 Enrolled
Vaccine Science

 

The Saudi Society of Clinical Pharmacy (SSCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

 

Course Content

Prioritizing Access to Modern Gene Therapies and Management Strategies for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy

  • Prioritizing Access to Modern Gene Therapies and Management Strategies for Spinal Muscular Atrophy and Duchenne Muscular Dystrophy

Evaluations Form

Free
Free access this course
  • Intermediate
  • 0 Total Enrolled
  • August 25, 2026 Last Updated
  • Certificate of completion
Durations:
Lectures: 1
Students: Max
Level: Intermediate
Language: English
Certificate: Yes